Raquel Almazan 2023-24 Event Dates
UPCOMING NEXT! La Lucha Arts presents: La Paloma Prisoner was programmed as part of the Next Door series with New York... Read More
CTH Commissions Almazan for Icons 2: El Barrio Lives! published in American Theatre Magazine
Almazan Commissioned by Classical Theatre of Harlem in collaboration with American Theatre Magazine present ICONS, co-produced with Venus Radio Theatre. This episode features... Read More
Almazan Featured on the 2023 Kilroys Web
Almazan selected for the 2023 Kilroys Web. VIEW THE WEB! https://thekilroys.org/web-2023/ Featured in American Theatre Magazine article. Read HERE https://www.americantheatre.org/2023/10/10/a-web-not-a-ranking-why-the-kilroys-upended-their-list/ THE WEB... Read More
Live & In Color Announces Raquel Almazan As The Recipient Of The 2023 June Bingham New Playwright Commission
Live & In Color Broadwayworld press release! Raquel Almazan’s to-be piece GODDESSES RETURN TO THE TEMPLE – FINAL INSTALLMENT OF A... Read More
Almazan awarded 2022 NYC Women’s Fund
Announcing: Raquel Almazan’s La Lucha Arts is a recipient of the 2022 Mayor’s Office of Media and Entertainment (MOME) Award NYC... Read More
2022 Resident Artist fellowship with Chelsea Factory/Interviewed by W Magazine
Moving into the new year with the announcement of being part of the inaugural cohort of artists for 2021-2022 with Chelsea Facgtory.... Read More
La Paloma Prisoner Project Awarded the Map Fund 2021
Soaring High as we share the news that La Paloma Prisoner Project is a 2021 Map Fund Grantee! Our world premiere production... Read More
Raquel Almazan named 2020 National Association of Latino Arts and Cultures Leadership Institute Fellow
Raquel Almazan named 2020 National Association of Latino Arts and Cultures Leadership Institute Fellow. https://www.nalac.org/members/member-tags/2020-nli-fellows/ Selected into the 2020 National Association of Latino... Read More
Almazan quoted in The New York Times – 20 Theatre Figures
Almazan, President of the Board of the Indie Theatre Fund is quoted in the New York Times in response to what... Read More